Procter & Gamble Health Limited

Procter & Gamble Health Limited

Procter & Gamble Health Limited has revised the date of its 59th Annual General Meeting for the Financial Year 2025-26 to September 3, 2026, and the record date for the purpose of AGM and final dividend to August 27, 2026.

Procter & Gamble Health Limited

Procter & Gamble Health Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the details of securities dematerialized or rematerialized during the quarter ended June 30, 2026, to the stock exchanges where the company's shares are listed.

Procter & Gamble Health Limited

Procter & Gamble Health Limited has informed the Exchange regarding 'Communication in respect of deduction of tax at source (TDS) on the amount of Dividend income from Procter & Gamble Health Limited (the Company)'. The company has recommended a final dividend of Rs. 45 per equity share of face value of Rs. 10 each for Company’s Financial Year 2025-26, subject to approval of the shareholders at the ensuing Annual General Meeting (AGM).

Procter & Gamble Health Limited

Procter & Gamble Health Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Procter & Gamble Health Limited

Procter & Gamble Health Limited has informed the Exchange regarding the appointment of Mr. Shine Matthew Sunny as Marketing Strategy and Planning leader, Commercial Excellence & E-commerce Leader of the company w.e.f. July 01, 2026.

Procter & Gamble Health Limited

Procter & Gamble Health Limited has informed the Exchange regarding the appointment of four new senior management personnel, effective July 1, 2026.

Procter & Gamble Health Limited

Procter & Gamble Health Limited has informed the Exchange regarding the appointment of Mr. M. Padmakar Rao as Sales Leader (North & West region) and Institutional Business Leader, effective July 01, 2026, along with other internal organizational changes.

Procter & Gamble Health Limited

Procter & Gamble Health Limited has informed the Exchange regarding the appointment of new sales leaders, effective July 1, 2026.